Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study

BACKGROUND: Type 2 diabetes mellitus is associated strongly with an increased risk of micro- and macro-vascular complications, leading to impaired quality of life and shortened life expectancy. In addition to appropriate glycemic control, multi-factorial intervention for a wide range of risk factors...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Tanaka, Atsushi, Murohara, Toyoaki, Taguchi, Isao, Eguchi, Kazuo, Suzuki, Makoto, Kitakaze, Masafumi, Sato, Yasunori, Ishizu, Tomoko, Higashi, Yukihito, Yamada, Hirotsugu, Nanasato, Mamoru, Shimabukuro, Michio, Teragawa, Hiroki, Ueda, Shinichiro, Kodera, Satoshi, Matsuhisa, Munehide, Kadokami, Toshiaki, Kario, Kazuomi, Nishio, Yoshihiko, Inoue, Teruo, Maemura, Koji, Oyama, Jun-ichi, Ohishi, Mitsuru, Sata, Masataka, Tomiyama, Hirofumi, Node, Koichi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5020545/
https://ncbi.nlm.nih.gov/pubmed/27619983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0449-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars